New England Journal of Medicine - CHIP-BCIS3

How do you stay at the cutting edge? By leading the research that establishes best practice in the field.

Over the last five years, Dr Ryan has co-led the CHIP-BCIS3 randomised controlled trial, testing whether the Impella device improves outcomes for patients undergoing complex PCI. Three hundred patients took part across 21 hospitals in the United Kingdom. The results have just been published in the New England Journal of Medicine. The results showed that the device did not improve patients outcomes, and the editorial comment in the journal highlighted that it is the skill and experience of the doctors performing the procedure that is most important in obtaining the results for patients.